Search results
Showing 91 to 105 of 159 results for surgical site infections
Is the use of chlorhexidine body wash associated with increased antimicrobial resistance?
wash. Mupirocin alone was effective in reducing Staphylococcus aureus infections caught in hospital in people who were identified as...
NICE has developed a medtech innovation briefing (MIB) on the S-Cath System for suprapubic catheterisations
The Debrisoft monofilament debridement pad for use in acute or chronic wounds (HTG334)
Evidence-based recommendations on the Debrisoft monofilament debridement pad for use in acute or chronic wounds.
LARS for reconstructing damaged intra-articular cruciate knee ligaments (MIB30)
NICE has developed a medtech innovation briefing (MIB) on LARS for reconstructing damaged intra-articular cruciate knee ligaments
Evidence-based recommendations on viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems).
TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation (MIB60)
NICE has developed a medtech innovation briefing (MIB) on the TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation
Summary of the evidence on antimicrobial prescribing: delafloxacin
NICE has developed a medtech innovation briefing (MIB) on Permacol for treating anal fistulae .
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
NICE has developed a medtech innovation briefing (MIB) on Mobi-C for cervical disc replacement
PROPEL sinus implants for maintaining sinus patency after surgery (MIB253)
NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery .
NICE has developed a medtech innovation briefing (MIB) on the ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation
Evidence-based recommendations on hand transplant surgery (allotransplantation). This involves transplanting a hand from a recently deceased donor onto the amputated stump.
View recommendations for HTG254Show all sections
Sections for HTG254
NICE has developed a medtech innovation briefing (MIB) on 24/7 EEG SubQ for epilepsy .
NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds .